Vlad Coric
CIK 1704317 · Chief Executive Officer · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$86.36M
Companies
4
Total Filings
40
Lifetime Open-Market Net
$28.52M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RPRX | Director | 15,343 | $62.32 | $956.2K | $0 | 3 | 2026-06-08 |
| BHVN | Chief Executive Officer | 3,006,673 | $15.74 | $47.33M | $26.52M | 30 | 2026-03-03 |
| MANE | Director | 390,514 | $97.51 | $38.08M | $2.00M | 1 | 2026-02-05 |
| Revance Therapeutics, Inc. (RVNC) Delisted | Director | 15,000 | $3.65 | $54.8K | $0 | 4 | 2025-02-06 |
Recent Filings · Page 3 of 4
40 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-11-01 | BHVN | Buy (P) | +25,800 | $412.0K | EDGAR |
| 2022-10-31 | BHVN | Buy (P) | +141,930 | $2.11M | EDGAR |
| 2022-10-26 | BHVN | Buy (P) | +853,380 | $8.96M | EDGAR |
| 2022-10-12 | BHVN | Other (J) | — | $0 | EDGAR |
| 2022-10-06 | BHVN | Buy (P) | +485,775 | $5.01M | EDGAR |
| 2022-10-05 | — | Mixed | +1,037,729 | -$56 | |
| 2022-10-05 | — | Other (J) | +461,470 | $0 | |
| 2022-10-03 | BHVN | Disp (D) | −922,941 | -$137.06M | EDGAR |
| 2022-01-07 | BHVN | Mixed | +12,012 | -$1.32M | EDGAR |
| 2021-11-26 | BHVN | Mixed | +5,875 | -$586.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.